Clinical trial
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients…
NCT00492687 · San Diego Pacific Oncology & Hematology Associates, Other · Unknown status
Key facts
| NCT number | NCT00492687 |
|---|---|
| Title | Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas |
| Official title | A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
| Lead sponsor | San Diego Pacific Oncology & Hematology Associates, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | carboplatin, tamoxifen citrate, temozolomide, adjuvant therapy, radiation therapy |
| Enrollment | 80 |
| Start date | Dec 1, 2006 |
| Primary completion | Jul 1, 2009 |
| First posted | Jun 27, 2007 |
| Last update posted | Jan 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: